Fig. 3From: A novel UHPLC‒MS/MS method for quantitative analysis of zanubrutinib in rat plasma: application to an in vivo interaction study between zanubrutinib and triazole antifungalMean plasma concentration-time curve of zanubrutinib in different treatment groups of rats. Group A: the control group (0.5% CMC-Na), Group B: 20 mg/kg isavuconazole and Group C: 20 mg/kg fluconazole (n = 6, mean ± SD).Back to article page